Japan will provide AstraZeneca vaccines manufactured in Japan to Malaysia
2021/6/15
Foreign Minister Motegi Toshimitsu announced today that the Government of Japan would like to provide AstraZeneca vaccines manufactured in Japan to Malaysia as well as Indonesia, the Philippines and Thailand from July, if various circumstances allow, and will advance its coordination.
Based on Foreign Minister’s announcement today, the Embassy of Japan in Malaysia will continue to work closely with the Government of Malaysia to provide the vaccine to the Malaysians. This will be another symbol of friendship between Japan and Malaysia.
＜For your information＞
Japanese international assistance to cope with COVID-19 includes the following；
（To Malaysia）
●Provision of medical equipment worth approximately $5 million to Malaysia
https://www.my.emb-japan.go.jp/itpr_en/newinfo_22012021B.html
●provision of humanitarian assistance worth approximately $2 million through international organization, UNICEF, UNHCR and IFCR
https://www.my.emb-japan.go.jp/itpr_ja/newinfo_21012021.html
●Grant of Avigan tablets
https://www.my.emb-japan.go.jp/itpr_en/newinfo_23102020.html
●Provision of Personal Protective Equipment (PPE) to NADMA through JICA
https://www.my.emb-japan.go.jp/itpr_en/newinfo_11022021.html
●Capacity building support through JICA, including strengthening of health and medical system and medium and long term capacity building
●provision of humanitarian assistance worth approximately $2 million through international organization, UNICEF, UNHCR and IFCR
https://www.my.emb-japan.go.jp/itpr_ja/newinfo_21012021.html
●Grant of Avigan tablets
https://www.my.emb-japan.go.jp/itpr_en/newinfo_23102020.html
●Provision of Personal Protective Equipment (PPE) to NADMA through JICA
https://www.my.emb-japan.go.jp/itpr_en/newinfo_11022021.html
●Capacity building support through JICA, including strengthening of health and medical system and medium and long term capacity building
（To ASEAN）
● Proposal for the establishment of “the ASEAN Centre for Public Health Emergencies and Emerging Diseases” as an organization to protect people in the ASEAN region from the threat of infectious diseases, and financial support of USD 50 million through JAIF
● Proposal for the establishment of “the ASEAN Centre for Public Health Emergencies and Emerging Diseases” as an organization to protect people in the ASEAN region from the threat of infectious diseases, and financial support of USD 50 million through JAIF
（To the world）
●Additional contribution to WHO (USD 50 million)
●Up to approximately $5 billion in loans globally over two years to support the emergency response to the COVID-19 crisis
●Assistance globally through UNICEF, UNHCR and other international organizations
https://www.my.emb-japan.go.jp/itpr_ja/newinfo_21012021B.html
●Support for medical equipment procurement worth approximately $480 million in total globally
●Financial support in total of USD 300 million to Gavi and others for the development and global distribution of vaccine (Contribution of USD130million for development of vaccine through GAVI and USD 170million for global distribution of vaccine through COVAX facilities)
●The Government of Japan held the COVAX AMC Summit with Gavi to raise additional funding to secure necessary vaccines for developing countries by the end of 2021, and announced Japan’s additional contribution of 800 million USD, which brings the total contribution of 1 billion USD to the COVAX Facility.
https://www.my.emb-japan.go.jp/itpr_en/newinfo_03062021.html